OneMedNet Accelerates Subscription Revenue Strategy with Industry-Leading Network Expansion: Clinical Exams Increase 37%, Patient Records Grow 38%

Rhea-AI Summary

OneMedNet (Nasdaq: ONMD) announced a major iRWD network expansion on November 20, 2025 that it says strengthens its subscription offerings and position as a leading regulatory-grade Real-World Data network.

Key metrics in the three months since August 2025: provider sites added ~380 to a total exceeding 2,130 (+22%); unique de-identified patient records increased by 13 million to > 47 million (+38%); clinical exams and images grew by 50 million to > 186 million (+37%).

The company said these expansions are accelerating its subscription model and recurring revenue as pharma, life-science, and AI customers seek ongoing access to longitudinal cohorts in the estimated $60 billion Real-World Evidence market.

Positive

• Provider sites +380 to >2,130 (+22%)
• Patient records +13M to >47M (+38%)
• Clinical exams and images +50M to >186M (+37%)

Negative

• None.

Insights

Market Data Strategy Expert

OneMedNet reports sharp network growth that supports subscription momentum and strengthens its RWD scale.

OneMedNet increased provider sites by ~380 to exceed 2,130 (a 22% expansion), added 13 million unique de‑identified patient records to surpass 47 million (38% growth), and expanded clinical exams and images by 50 million to exceed 186 million (37%). These three concrete, simultaneous gains raise the raw scale and dimensionality of its regulatory‑grade Real‑World Data offering and directly align with a subscription model that sells ongoing access to longitudinal cohorts.

Key dependencies and risks remain clear from the facts disclosed: subscription momentum depends on converting scale into recurring contracts and sustaining data refresh cadence; the company links growth to expanded customer commitments but provides no revenue or ARR figures to confirm monetization. The claim of a position in a $60 billion market offers context but does not quantify OneMedNet's share or financial impact.

Monitorable items: customer contract renewals and ARR or subscriber counts, reported revenue impact in upcoming releases, and whether the company sustains similar quarterly network gains starting from August 2025. Near‑term evidence of impact should appear within one to two fiscal quarters following this expansion.

MINNEAPOLIS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the curator and provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a significant network expansion that materially strengthens its position as one of the largest live Real-World Data networks in the world and supports the company’s subscription offerings.

In the three months since August 2025, OneMedNet has expanded its iRWD™ network as follows:

• Added approximately 380 provider sites → total now exceeding 2,130 (+22% network scale)
• Increased unique de-identified patient records by 13 million → total now exceeding 47 million (+38%)
• Expanded clinical exams and images by 50 million → total now exceeding 186 million (+37%)
  

This rapid, multi-dimensional growth cements OneMedNet’s leadership as the largest continuously refreshed, regulatory-grade Real-World Data network globally.

“Our subscription model is now gaining significant momentum,” said Aaron Green, President & CEO of OneMedNet. “In the $60 billion Real-World Evidence market¹, pharmaceutical, life-science, and AI customers subscribe to our platform for ongoing access to the precise, diverse, and longitudinal cohorts they require. Each incremental expansion of sites, encounters, and clinical exams materially enhances the depth, specificity, and value of those data feeds. The result is a powerful virtuous cycle: existing subscribers expand their commitments; new customers commit to long term partnerships and annual recurring revenue accelerates. Today’s milestone unequivocally positions OneMedNet to capture a growing share of this market opportunity.”

¹ Real World Evidence Solutions Market – https://www.grandviewresearch.com/industry-analysis/real-world-evidence-solutions-market-report

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 2,130 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements.  We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial and operational performance , debt reductions, and their effect on achieving operational strategies of the company. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Digital Assets, including Digital Asset’s volatility; and our ability to implement our Digital Asset treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What network growth did OneMedNet (ONMD) report on November 20, 2025?

OneMedNet reported adding ~380 provider sites to >2,130 (+22%), +13M patient records to >47M (+38%), and +50M clinical exams/images to >186M (+37%).

How does OneMedNet say the November 2025 expansion affects ONMD's subscription business?

The company said the expansion deepens data feeds, prompting existing subscribers to expand commitments and accelerating annual recurring revenue.

What time period covers the growth figures OneMedNet disclosed in November 2025?

The company said the changes occurred in the three months since August 2025.

What total patient record and clinical exam counts did OneMedNet disclose on Nov 20, 2025?

OneMedNet disclosed >47 million unique de-identified patient records and >186 million clinical exams and images.

What market size did OneMedNet reference in the November 20, 2025 announcement?

OneMedNet referenced a $60 billion Real-World Evidence market estimate.

Will the November 2025 iRWD expansion likely affect ONMD revenue immediately?

The announcement states subscription momentum and accelerating recurring revenue but does not disclose specific revenue or ARR figures.